AMIC looks to down-classify brachytherapy's FDA status

Advanced Medical Isotope Corp. considers pursuing regulatory down-classification for its brachytherapy cancer product. Washington-based Advanced Medical Isotope Corp. is evaluating its options for U.S. market approval of its proprietary brachytherapy cancer product, the company announced. Advanced Medical Isotope Corp., Food & Drug Administration (FDA)News Well, Regulatory/Clearance, Brachytherapy, Food & Drug Administration (FDA), Oncology, Pre-Market Approval (PMA), Radiosurgeryread more
Source: Mass Device - Category: Medical Equipment Authors: Source Type: news